CVS Agrees To Pay $37M To Settle Claims That It Fraudulently Billed Medicaid For More Costly Form Of Heartburn Medication
CVS Caremark on Tuesday agreed to pay $36.7 million to settle allegations that the company overbilled Medicaid for the antacid ranitidine, a generic version of Zantac, for more than six years, the Chicago Tribune reports (Sachdev, Chicago Tribune, 3/19).
More: continued here
Filed under: Medical Malpractice / Litigation on April 2nd, 2008